News on Legislation and Expert Insights on Medical Device Registration — KREDO

In professional circles, medical device (MD) registration is typically viewed through a legal lens. The main focus falls on documentation requirements, testing, expert reviews, and regulatory interaction procedures. As a result, registration delays are often perceived as purely procedural setbacks. Yet the real damage unfolds in the economic dimension — and it is far more substantial than it appears at first glance. In this article, we calculate what six months of delay actually costs a business, and why proactive risk management is the only rational strategy.

In contemporary medical practice, relying solely on the concept of the "average patient" is no longer sufficient. The same diagnosis may conceal different biological disease mechanisms, varying sensitivity to therapy, and differing prognoses. Of course, standard protocols remain relevant — they form the backbone of evidence-based medicine. But they are increasingly being supplemented by individual patient profiles that account for genetics, lifestyle, comorbidities, and treatment history. This shift is not a trend but a structural change in how medicine is practiced.

For a long time, service businesses grew by a simple formula: more clients — more staff. But that model is outdated. Today, scaling effectively while maintaining quality requires not just hiring, but transforming processes. In this article, we explore which AI-powered tools are actually reshaping service delivery, and why this shift has become a strategic imperative rather than an option.

The Russian healthcare market is undergoing a platform transformation: instead of fragmented clinics, services, and data, integrated ecosystems are forming in which the key value lies not in individual medical assets, but in the ability to build a unified digital and operational environment. This shift is reshaping competitive dynamics, patient expectations, and the logic of investment in the sector.

Personalized medicine has long moved beyond theoretical debate and become a practical tool — we simply rarely notice the mechanics when processes run in the background. Previously, therapy selection was largely a process of trial and error; today, systems propose options even before a patient's first appointment. This shift is driven by big data automation and artificial intelligence, which are quietly redefining clinical practice.

Selecting treatment for a patient before they even see a doctor is a practice that is gradually becoming the norm. As Yegor Kashka, COO of KREDO.TECH, explained, these capabilities have emerged thanks to big data and artificial intelligence: systems analyze millions of cases and identify patterns that no specialist could process manually. But does this mean doctors will soon be replaced? The expert shares his view.

In Russia, 24% of companies have already officially integrated artificial intelligence technologies into their business processes, while another portion uses neural networks situationally, according to joint research by mobile operator Beeline and the Managers Association.

For a long time, the healthcare landscape was fairly straightforward. The strongest players were those with more clinics, broader networks, more expensive equipment, and better locations. That genuinely worked. But now, it seems, the old rules no longer apply.

Healthcare is entering one of the most sweeping phases of transformation in recent decades. The rise of artificial intelligence, digital platforms, telemedicine, and online medical device markets is gradually reshaping not only clinical practice but the entire industry infrastructure — from regulation and device registration to patient interaction models and the economics of medical businesses.

In Russian healthcare, the term "patient-centricity" has long entered the professional vocabulary. It appears regularly in strategies, presentations, and industry discussions. But the more frequently it is used, the sharper the question becomes: what does it actually mean in practice? According to the CEO of KREDO.TECH, true patient-centricity is not a set of service standards but a systemic redesign of how healthcare institutions and medical businesses are organized.

Discussions about artificial intelligence in healthcare have long been dominated by two extremes. Some saw AI as a revolution that had already arrived; others feared that technology would soon begin replacing physicians. But, as is often the case, reality turned out to be less dramatic — and far more significant.

Digital transformation in medicine has long since become an urgent necessity rather than a future prospect. The industry faces rising patient expectations, increasingly complex treatments, and a shortage of physician time. In 2024, the global digital health market reached significant scale, and Russia is no exception to this trend — although it follows its own regulatory and infrastructural logic.

Digital transformation in medicine has long since become an urgent necessity rather than a future prospect. The industry faces rising patient expectations, increasingly complex treatments, and a shortage of physician time. In 2024, the global digital health market reached significant scale — and Russia is part of this dynamic, albeit on its own regulatory and infrastructural terms.

Over the past decade, the vertically integrated model — in which a company seeks to perform all functions in-house — has gradually given way to more flexible management approaches. Even companies with strong engineering cultures and well-established operational systems are increasingly outsourcing functions that fall outside their core competencies. This is not a sign of weakness but a rational response to the growing complexity of markets, technologies, and regulatory requirements.

The Moscow Chamber of Commerce and Industry hosted a roundtable discussion on "Healthcare Digitalization and Artificial Intelligence in Medicine." The event was organized by the MCCI Committee on Healthcare and the Medical Industry for medical device manufacturers, authorized representatives, importers, distributors, and other participants in the medical device market.

The State Duma held a roundtable discussion on the introduction of artificial intelligence technologies into the medical device registration process — particularly for medical rehabilitation devices, as reported by KREDO, which also participated in the discussion.

EAEU member states have signed a protocol expanding the list of medical devices that may circulate without registration within the union. What new opportunities does this create for market participants?

You have invested millions in development and testing. Your medical device is a technological breakthrough. But what can stop it is not a product defect — it is an error in a document. Missed deadlines, additional expert reviews, and even product recalls are often the result of legal missteps at the outset, not technical failures. In this article, we examine five of the most common pitfalls in medical device registration and explain how to avoid them.

Andrei Antonov, founder and CEO of KREDO — a digital ecosystem for medical device registration — discusses how modern medicine is influencing demographics. Over the past century, active life expectancy in developed countries has increased significantly, and the medical sector has played a central role in this transformation. But medicine today is no longer just about treating disease — it is becoming an instrument of demographic policy.

In 2025, medical device registration in Russia entered a new stage: AI-powered automation ceased to be merely a convenient add-on and became an effective tool for streamlining and accelerating the issuance of registration certificates. This raises a new and pressing question for the industry — when a system makes an error, who is responsible: the algorithm, the developer, or the expert who signed off on the result?

Systemic failures in the medical device registration market are the result of an outdated process architecture that no longer meets the complexity of modern regulatory requirements. Manual, inertia-driven consulting is being replaced by the KREDO ecosystem, which introduces AI automation and parallel task execution — reducing the timeline from the industry standard of 12–18 months to 3–6 months.

Incorrect technical specifications have become one of the leading causes of product blocks on marketplaces. Documentation errors cost sellers lost revenue, and restoring sales can take months. We examine the five most common and costly mistakes.

Russian President Vladimir Putin's address at Sber's AI Journey 2025 conference and recent government statements set new strategic parameters for the market: AI is becoming fundamental infrastructure for the Russian economy. We are talking not about experimental pilots but about systemic integration of AI into key sectors — including healthcare and medical device regulation.

In 2024–2025, Russian marketplaces faced an unprecedented tightening of controls over the sale of medical and quasi-medical devices. Driven by regulatory changes, increased activity from Roszdravnadzor, and a surge in parallel imports, platforms began mass-blocking products that did not meet the updated documentation requirements. What has changed — and how can sellers protect themselves?

Over the past century, active life expectancy in developed countries has increased by approximately five decades — a scale of change comparable to the industrial revolution or the computer age. This is not merely an improvement in living conditions: it represents a fundamental shift in the structure of human life itself, with profound implications for healthcare, business models, and demographic policy.

KREDO (KREDO.TECH) has released an updated analytical report on the use of its free AI-powered tool for automated verification of medical device registration dossiers — the Kredo_AI_bot.

In recent months, marketplaces such as Ozon, Wildberries, and others have dramatically tightened their document verification requirements for medical devices. Reviews now take place before a listing is published, and mass blocks of already-listed products have become commonplace. As a result, products that were generating tens or hundreds of orders per day are suddenly frozen — and restoring access takes time, money, and nerves.

KREDO announces the launch of Labbroker — a free service and Russia's first digital accelerator platform that simplifies interaction between testing laboratories and medical device manufacturers.

The integration of artificial intelligence into medical practice opens new frontiers in diagnostics — but simultaneously creates a zone of serious legal uncertainty. Despite the absence of high-profile court precedents, experts warn that the legal groundwork for AI-related liability claims is already in place, and the first major cases are only a matter of time.

Medical device registration in Russia is no longer just a bureaucratic formality — it has become a test of business maturity, readiness to exit the regulatory gray zone, and accountability to distributors, consumers, and the state. Against the backdrop of technological growth, digitalization, and rising regulatory standards, companies that are unprepared for the process face not just delays, but real financial losses.

The Russian e-commerce market is entering a phase of maturity — and with it comes a new wave of regulation. Where marketplaces once competed on assortment and price, product safety and legal compliance are now becoming the primary concerns.

Artificial intelligence is increasingly making its way into every aspect of our lives — and medicine is no exception. Nearly half of all healthcare organizations are now implementing AI-driven solutions. We hear about applications in disease diagnostics and treatment planning almost daily. But there is another area where AI is delivering a real impact: medical device registration. We examine how intelligent tools are changing this process.

Medical device registration is a multi-component, labor-intensive procedure that frequently involves bureaucratic delays. The introduction of a digital ecosystem covering every stage — from laboratory selection to receipt of the registration certificate — has the potential to transform this chain, reduce costs, and cut timelines significantly.

As of 1 March 2025, Russia introduced new rules for the state registration of medical devices, approved by Government Resolution No. 1684 of 30 November 2024. These changes are designed to simplify and accelerate the process of obtaining registration certificates — particularly for innovative medical technologies. This guide explains what the new requirements mean in practice.